B cell receptor signaling pathway |
|
|
|
|
NM_008528 |
Blnk*Δ |
B-cell linker |
2.4 |
0.000 |
1.6 |
0.027 |
NM_013482 |
Btk*Δ |
Bruton agammaglobulinemia tyrosine kinase |
2.0 |
0.008 |
1.3 |
0.037 |
NM_010187 |
Fcgr2b*Δ |
Fc receptor, IgG, low affinity IIb |
2.5 |
0.000 |
1.6 |
0.000 |
NM_026820 |
Ifitm1*Δ |
interferon induced transmembrane protein 1 |
1.5 |
0.001 |
1.8 |
0.001 |
NM_011691
|
Vav1*Δ
|
vav1 oncogene
|
2.2
|
0.005
|
1.4
|
0.005
|
complement and coagulation cascades pathway |
|
|
|
|
NM_007572 |
C1qa*Δ |
complement component 1, q subcomponent, alpha polypeptide |
2.3 |
0.000 |
1.9 |
0.000 |
NM_009777 |
C1qb*Δ |
complement component 1, q subcomponent, beta polypeptide |
2.2 |
0.001 |
2.3 |
0.001 |
NM_013484 |
C2*Δ |
complement component 2 (within H-2S) |
2.3 |
0.000 |
1.9 |
0.001 |
NM_009778 |
C3*Δ |
complement component 3 |
2.9 |
0.001 |
1.3 |
0.036 |
NM_009776
|
Serping1*Δ
|
serine (or cysteine) peptidase inhibitor, clade G, member 1
|
1.3
|
0.010
|
1.4
|
0.015
|
Leukocyte transendothelial migration pathway |
|
|
|
|
NM_008770 |
Cldn11*Δ |
claudin 11 |
−1.5 |
0.020 |
−1.3 |
0.004 |
NM_019500 |
Cldn14*Δ |
claudin 14 |
−1.4 |
0.046 |
−1.4 |
0.013 |
NM_007806 |
Cyba*Δ |
cytochrome b-245, alpha polypeptide |
1.7 |
0.006 |
1.7 |
0.001 |
BC008626 |
Icam1*Δ |
intercellular adhesion molecule |
2.5 |
0.001 |
1.8 |
0.003 |
NM_011691 |
Vav1*Δ |
vavl oncogene |
2.2 |
0.005 |
1.4 |
0.005 |